Diligence memo · auto-generated · as of July 2, 2026

Gerosynth Laboratories, Inc.

Gerosynth Laboratories, Inc. looks under-valued against its niche peers and is quiet on financing cadence.

SourceModeled below same-niche peers while still financing on rhythm — a potential mispricing worth a closer look.

Businessfiled

Gerosynth Laboratories, Inc. operates in Other, based in Bloomington.

Sector still resolves to a broad 'Other' bucket, so operating comparables below are weaker than for a tightly-classified peer.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Gerosynth Laboratories, Inc. has raised $6.0M in disclosed capital across 4 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).

Largest single filing: $2.7M on 2023-10-18.

Most recent recorded round closed around 2024-12-02.

Valuation (modeled)modeled

Provath models Gerosynth Laboratories, Inc. at approximately $5.9M (range $1.5M–$14M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Under-valued. Modeled value is 0.52× the median modeled value of Seed Other companies in 2022–2024 (1231 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Historic cadence: a new round about every 5 months.

Last raise 19 mo ago; this sector typically re-raises about every 11 months.

Slightly overdue versus sector cadence.

The last round stepped up 1.2× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 69% of Other peers (25015 compared).

Modeled value ranks above 29% of those peers.

Closest niche peers: Dropee Inc., NFH Northern Project Development, LLC, FactorFund-Note-2022 LLC, Immersion Elements LLC, Possip, Inc..

Peoplefiled

9 named people on file across officers, directors and signatories.

Risks & flagsmixed

Broad sector classification weakens peer comparison.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.